Cellectar Biosciences CLRB 深 沪
已收盘 09-20 16:00:00 美东时间
2.07
-0.040
-1.90%
华盛通- 最 高2.11
- 今 开2.11
- 成交量 23.84万股
- 最 低 2.03
- 昨 收 2.11
- 总市值 2543.68万
- 52周最高 4.45
- 市盈率 静 --
- 换手率 1.94%
- 52周最低 1.82
- 委 比 -9.81%
- 总股本 1228.83万
- 历史最高 9200.00
- 量 比 0.90
- 振 幅 3.79%
- 历史最低 1.30
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Perspective gets FDA fast track status for radiopharmaceutical VMT101
Shares of Perspective Therapeutics (NYSE:CATX) rose 4% in midday trading Thursday after the company said it had received FDA Fast Track Designation for its radiopharmaceutical candidate VMT101 for MC1...
09-06 01:16
Novartis expands U.S. radiopharma production amid rising competition
Novartis (NYSE:NVS) on Wednesday announced the construction of two new radioligand therapy (RLT) manufacturing facilities in the U.S. as the company faces stiff competition in the radiopharma space. T...
09-04 20:56
Cellectar Biosciences Faces Nasdaq Compliance Issue
Cellectar Biosciences (CLRB) has provided an announcement. The Company has been...
08-24 05:47
Cellectar receives delinquency notification letter from Nasdaq, co to restate financial statements
Cellectar Biosciences (NASDAQ:CLRB) on Friday said it has received a delinquency notification letter from Nasdaq. The notice indicated that the company is not in compliance with the periodic financial...
08-24 05:27
快讯 | Cellectar将重新编制之前发布的财务报表 - 公司宣布收到纳斯达克预期违约通知信
Cellectar to Restate Previously Issued Financial Statements – Company Announces...
08-24 05:00
快讯 | cellectar biosciences: 因无法在8月14日前提交截至6月30日的季度报告
Cellectar Biosciences: Unable to File Quarterly Report for Quarter Ended June 3...
08-15 05:03
快讯 | Cellectar：重新评估2022年10月完成的融资中发行的权证的会计处理方式
Cellectar: To Re-Evaluate Accounting Treatment for Warrants Issued in Financing...
08-15 05:03
Cellectar Biosciences reports Q2 results
Cellectar Biosciences press release (NASDAQ:CLRB): Q2 net cash used in operating activities during the three months ended June 30, 2024, was approximately $14.1 million. As of June 30, 2024, the compa...
08-13 18:53
快讯 | cellectar biosciences: 截至6月30日的现金余额足以支撑基本预算运营至2025年第2季度。
Cellectar Biosciences: Cash Balance as of June 30 Adequate to Fund Basic Budget...
08-13 18:41
快讯 | cellectar biosciences报告2024年第二季度财务业绩并提供企业更新
Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corp...
08-13 18:40
